Sandy Spring Bank Astrazeneca PLC Transaction History

Sandy Spring Bank

$2.4 Billion
Q3 2024

A detailed history of Sandy Spring Bank transactions in Astrazeneca PLC stock. As of the latest transaction made, Sandy Spring Bank holds 69,806 shares of AZN stock, worth $4.99 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

69,806

Previous 57,989 20.38%

Holding current value

$4.99 Million

Previous $4.52 Million 20.28%

% of portfolio

0.23%

Previous 0.2%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$76.67 - $87.62 $906,009 - $1.04 Million	11,817 Added 20.38%	69,806 $5.44 Million
Q2 2024 Aug 06, 2024	BUY	$66.81 - $80.83 $1.23 Million - $1.49 Million	18,412 Added 46.52%	57,989 $4.52 Million
Q1 2024 May 08, 2024	BUY	$61.03 - $69.57 $2.27 Million - $2.59 Million	37,168 Added 1542.88%	39,577 $2.68 Million
Q4 2023 Jan 26, 2024	BUY	$61.89 - $69.28 $39,919 - $44,685	645 Added 36.56%	2,409 $162,000
Q3 2023 Oct 30, 2023	SELL	$64.85 - $71.7 $57,262 - $63,311	-883 Reduced 33.36%	1,764 $119,000
Q2 2023 Aug 04, 2023	BUY	$69.91 - $75.81 $5,732 - $6,216	82 Added 3.2%	2,647 $189,000
Q1 2023 May 05, 2023	BUY	$63.15 - $71.6 $38,079 - $43,174	603 Added 30.73%	2,565 $178,000
Q3 2022 Nov 02, 2022	SELL	$53.02 - $135.75 $18,557 - $47,512	-350 Reduced 15.14%	1,962 $107,000
Q2 2022 Jul 21, 2022	SELL	$59.26 - $71.14 $20,741 - $24,899	-350 Reduced 13.15%	2,312 $153,000
Q1 2022 May 03, 2022	SELL	$55.72 - $67.12 $19,502 - $23,492	-350 Reduced 11.62%	2,662 $177,000
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $21,608 - $25,532	-400 Reduced 11.72%	3,012 $176,000
Q3 2021 Nov 05, 2021	SELL	$55.56 - $60.79 $36,114 - $39,513	-650 Reduced 16.0%	3,412 $205,000
Q2 2021 Aug 09, 2021	SELL	$48.42 - $60.18 $4,842 - $6,018	-100 Reduced 2.4%	4,062 $244,000
Q1 2021 May 03, 2021	SELL	$47.16 - $54.44 $4,338 - $5,008	-92 Reduced 2.16%	4,162 $207,000
Q4 2020 Feb 03, 2021	BUY	$48.52 - $58.02 $3,008 - $3,597	62 Added 1.48%	4,254 $213,000
Q3 2020 Nov 09, 2020	BUY	$53.07 - $61.1 $29,029 - $33,421	547 Added 15.01%	4,192 $230,000
Q2 2020 Aug 12, 2020	SELL	$43.1 - $55.31 $948 - $1,216	-22 Reduced 0.6%	3,645 $193,000
Q1 2020 May 01, 2020	BUY	$37.79 - $51.33 $4,988 - $6,775	132 Added 3.73%	3,667 $164,000
Q4 2019 Feb 06, 2020	BUY	$42.46 - $50.46 $1,486 - $1,766	35 Added 1.0%	3,535 $177,000
Q3 2019 Nov 01, 2019	SELL	$40.12 - $45.47 $3,410 - $3,864	-85 Reduced 2.37%	3,500 $156,000
Q4 2018 Feb 08, 2019	BUY	$36.86 - $41.49 $36,860 - $41,490	1,000 Added 38.68%	3,585 $136,000
Q3 2018 Nov 07, 2018	SELL	$34.76 - $39.72 $26,591 - $30,385	-765 Reduced 22.84%	2,585 $102,000
Q2 2018 Aug 03, 2018	SELL	$34.55 - $37.05 $49,751 - $53,351	-1,440 Reduced 30.06%	3,350 $118,000
Q1 2018 May 04, 2018	SELL	$32.97 - $36.63 $17,573 - $19,523	-533 Reduced 10.01%	4,790 $168,000
Q4 2017 Feb 02, 2018	BUY	$32.09 - $34.78 $10,718 - $11,616	334 Added 6.69%	5,323 $185,000
Q3 2017 Nov 03, 2017	SELL	$28.96 - $34.0 $46,654 - $54,774	-1,611 Reduced 24.41%	4,989 $169,000
Q2 2017 Aug 11, 2017	BUY	N/A	6,600	6,600 $225,000

Others Institutions Holding AZN

# of Institutions

1,345

Shares Held

492M

Call Options Held

4.99M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $221B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

News

Stay updated on Sandy Spring Bank with notifications on news.

Account

Sandy Spring Bank Astrazeneca PLC Transaction History